Skip to main content
. 2017 Dec 22;20(4):253–263. doi: 10.5770/cgj.20.293

TABLE 3.

Rank of the top medication optimization priorities identified from final round of Delphi process (live vote)

Final Rank Score (x/9) Priority
1 7.3 Improving efforts (e.g., funding) towards developing novel technologies innovations focused on facilitating appropriate medication prescribing and/or deprescribing in older adults living with frailty.
2 6.5 Increasing research into developing or improving models that facilitate pharmacists playing an active role in the process of monitoring and assessing use of potentially inappropriate medications.
2 6.5 Further research into the values and preferences held by elderly patients living with frailty with respect to medication use (e.g., determine perspectives regarding appropriate medication prescription or deprescribing).
3 6.4 Building an (electronic) system and practice system so that a patient’s medications can be monitored and reviewed in real time to determine the current need and appropriateness of each medication, as well as potential for adverse drug–drug interactions.
3 6.4 Advocacy for clinical trials that specifically evaluate the therapeutic benefit and adverse effects of new and current medications on seniors living with frailty. [merged and edited]
4 6.2 New innovations being developed so that patients (and their trained care providers) are empowered to monitor and assess their own medication use.
5 4.9 Promoting and supporting the development of a nation-wide Pharmacare plan for all Canadians.